The preventive effects of mupirocin against nasotracheal intubation-related bacterial carriage

Anesthesia and Analgesia

Volumn 97, Issue 1, 2003, Pages 222-225

  Takahashi, Satoshi ^a   Minami, Kouichiro ^a   Ogawa, Midori ^a   Miyamoto, Hiroshi ^a   Ikemura, Kunio ^a   Shigematsu, Akio ^a   Taniguchi, Hatsumi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; PLACEBO; PROPOFOL; PSEUDOMONIC ACID; VECURONIUM;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOTRACHEAL TUBE; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NASOTRACHEAL INTUBATION; NOSE CAVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0037636165     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000066258.20778.06     Document Type: Article

References (19)

1. Mackenzie IC, Binnie WH. Recent advances in oral mucosal research. J Oral Pathol 1983;12:389-415.
2. Hariri MA, Duncan PW. Infective complications of brief nasotracheal intubation. J Laryngol Otol 1989;103:1217-8.
3. Holzapfel L, Chevret S, Madinier G, et al. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Crit Care Med 1993;21:1132-8.
4. Owen MK. Prevalence of oral methicillin-resistant Staphylococcus aureus in an institutionalized veterans population. Spec Care Dentist 1994;14:75-9.
5. Kluytmans J. Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus. J Hosp Infect 1998;40:S25-9.
6. Boelaert JR, De Smedt RA, De Baere YA, et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989;4:278-81.
7. Kluytmans JA, Manders MJ, van Bommel E, et al. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996;17:793-7.
8. Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:780-5.
9. Hill RL, Duckworth GJ, Casewell MW. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother 1988;22:377-84.
10. Murakami K, Minamide W, Wada K, et al. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991;29:2240-4.
11. Chastre J, Trouillet JL. Nosocomial pneumonia. Curr Opin Pulm Med 1995;1:194-201.
12. Roppolo LP, Vilke GM, Chan TC, et al. Nasotracheal intubation in the emergency department, revisited. J Emerg Med 1999;17:791-9.
13. Dupeyron C, Campillo SB, Mangeney N, et al. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections. Infect Control Hosp Epidemiol 2001;22:427-32.
14. Corbella X, Dominguez MA, Pujol M, et al. Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997;16:351-7.
15. Redhead RJ, Lamb YJ, Rowsell RB. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage. Br J Clin Pract 1991;45:252-4.
16. Dinner M, Tjeuw M, Artusio JF Jr. Bacteremia as a complication of nasotracheal intubation. Anesth Analg 1987;66:460-2.
17. Schmidt RM, Rosenkranz HS. Antimicrobial activity of local anesthetics: lidocaine and procaine. J Infect Dis 1970;121:597-607.
18. Hill RL, Casewell MW. Nasal carriage of MRSA: the role of mupirocin and outlook for resistance. Drugs Exp Clin Res 1990;16:397-402.
19. Casewell MW, Hill RL. In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1985;15:523-31.